Price Wealth’s Quest Diagnostics DGX Stock Holding History

Price Wealth’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$256K	Sell	2,238 -7,136	-76%	-$843K	0.07%	70
2020 Q2	$1.07M	Sell	9,374 -727	-7%	-$77.1K	0.32%	29
2020 Q1	$811K	Buy	10,101 +882	+10%	+$91.3K	0.29%	34
2019 Q4	$984K	Sell	9,219 -33	-0.4%	-$3.44K	0.31%	30
2019 Q3	$990K	Buy	9,252 +765	+9%	+$78.5K	0.32%	29
2019 Q2	$864K	Buy	8,487 +707	+9%	+$67.9K	0.28%	31
2019 Q1	$700K	Hold	7,780	–	–	0.27%	34
2018 Q4	$648K	Buy	7,780 +575	+8%	+$53.9K	0.27%	31
2018 Q3	$777K	Hold	7,205	–	–	0.29%	28
2018 Q2	$792K	Buy	7,205 +1,305	+22%	+$136K	0.3%	35
2018 Q1	$591K	Buy	5,900 +2,385	+68%	+$244K	0.35%	41
2017 Q4	$346K	Buy	+3,515	New	+$333K	0.23%	22

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Price Wealth's DGX Position: Q3 2020 in Review

Price Wealth reduced its Quest Diagnostics (DGX) stake by 76% in Q3 2020, selling an estimated $843K and leaving 2,238 shares worth $256K. The position accounts for 0.07% of the portfolio, ranked #70.

Price Wealth first reported a position in DGX in Q4 2017 and has held it in 12 quarters since. The position peaked at $1.07M in Q2 2020. 757 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

Price Wealth held 2,238 shares of Quest Diagnostics worth $256K as of Q3 2020.
Price Wealth sold 7,136 Quest Diagnostics shares in Q3 2020, an estimated $843K.
Quest Diagnostics made up 0.07% of Price Wealth's portfolio in Q3 2020, its #70 holding.
Price Wealth first reported a position in Quest Diagnostics in Q4 2017 and has held it in 12 quarters since.
Price Wealth's Quest Diagnostics position peaked at $1.07M in Q2 2020.
757 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.